SANKYO C15
Generic Name: olmesartan
Pill imprint SANKYO C15 has been identified as Benicar 40 mg.
Benicar is used in the treatment of high blood pressure; migraine prevention and belongs to the drug class angiotensin II inhibitors. There is positive evidence of human fetal risk during pregnancy.
Benicar 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Benicar Images
- Generic Name:
- olmesartan
- Imprint:
-
SANKYO
C15 - Strength:
- 40 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- hydroxypropyl cellulose
hypromellose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
magnesium silicate
titanium dioxide
- Drug Class:
- Angiotensin II inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sankyo Pharma
- National Drug Code (NDC):
- 65597-0104
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4885 | Physicians Total Care Inc (repackager) |
| 58016-0053 | Southwood Pharmaceuticals Inc (repackager) |
| 55289-0436 | PDRX Pharmaceuticals Inc (repackager) |
| 35356-0216 | Lake Erie Medical and Surgical Supply (repackager) |
| 23490-9410 | Palmetto State Pharmaceuticals Inc (repackager) |
| 68258-6995 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.


